Skip to main content
Clinical Trials/NCT07511751
NCT07511751RecruitingNot Applicable

COMPARATIVE EFFECTIVENESS OFF DRY NEEDLING, EXTRACORPOREAL SHOCK WAVE THERAPY, AND TRANSCUTANEOUS PULSED RADIOFREQUENCY IN PATIENTS WITH MYOFASCIAL PAIN SYNDROME: A PROSPECTIVE, RANDOMIZED CONTROLLED TRIAL

ALİEMAN1 site in 1 country60 target enrollmentStarted: March 10, 2026Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Recruiting
Sponsor
Enrollment
60
Locations
1
Primary Endpoint
Pain Intensity

Study Overview

Brief Summary

This study aims to compare the effectiveness of dry needling, extracorporeal shock wave therapy (ESWT), and pulsed radiofrequency (PRF) in patients with chronic musculoskeletal pain. The primary outcomes include pain intensity and functional status. Patients will be randomly assigned to different treatment groups, and outcomes will be evaluated before and after the interventions. The results of this study are expected to contribute to determining the most effective treatment method for pain management.

Detailed Description

Myofascial pain syndrome is a common musculoskeletal disorder characterized by trigger points and chronic pain. Various treatment modalities such as dry needling, extracorporeal shock wave therapy (ESWT), and pulsed radiofrequency (PRF) are used in clinical practice; however, there is no clear consensus on the most effective approach.

This randomized, parallel-group study aims to compare the effectiveness of these three treatment methods in patients diagnosed with myofascial pain syndrome. Eligible patients aged between 18 and 65 years with chronic back pain lasting at least 3 months will be included in the study. Participants will be randomly assigned to receive dry needling, ESWT, or PRF treatment.

Pain intensity will be assessed using the Numeric Rating Scale (NRS), and functional outcomes will also be evaluated. The study is expected to contribute to the current literature by providing comparative data on these commonly used treatment modalities and guiding clinical decision-making.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to 65 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Age between 18 and 65 years
  • Clinically diagnosed myofascial pain syndrome
  • Back pain lasting at least 3 months
  • Failure to respond to conservative treatments

Exclusion Criteria

  • History of cervical surgery or cervical disc pathology
  • Fibromyalgia
  • Shoulder pathologies
  • Coagulation disorders or use of anticoagulant therapy
  • Infection, malignancy, or inflammatory spinal diseases

Arms & Interventions

Dry Needling Group

Experimental

Patients receiving dry needling treatment.

Intervention: Dry Needling (Procedure)

ESWT Group

Experimental

Patients receiving extracorporeal shock wave therapy (ESWT)

Intervention: Extracorporeal Shock Wave Therapy (Procedure)

PRF Group

Experimental

Patients receiving pulsed radiofrequency (PRF) treatment.

Intervention: Pulsed radiofrequency(PRF) (Procedure)

Outcomes

Primary Outcomes

Pain Intensity

Time Frame: Baseline, 1 month, and 3 months after treatment

Pain intensity will be assessed using the Numeric Rating Scale(NRS). Pain intensity will be assessed using the Numeric Rating Scale (NRS), ranging from 0 (no pain) to 10 (worst imaginable pain). Higher scores indicate greater pain severity.

Secondary Outcomes

  • Pressure Pain Threshold(Baseline, 1 month, and 3 months after treatment)
  • Neck Disability Index (NDI)(Baseline, 1 month, and 3 months after treatment)
  • Quality of Life (SF-12(Baseline, 1 month, and 3 months after treatment)

Investigators

Sponsor
ALİEMAN
Sponsor Class
Other
Responsible Party
Sponsor Investigator
Principal Investigator

ALİEMAN

Associate Professor, Department of Anesthesiology and Reanimation

Sakarya University

Study Sites (1)

Loading locations...

Similar Trials